2591300-72-8
Chemical Structure
STING agonist-20
- CAS No.: 2591300-72-8
- Formula:C36H39N11O8
- Molecular Weight:753.76
IUPAC Name: (E)-N-(5-carbamoyl-1-(4-(6-carbamoyl-2-(4-ethyl-2-methyloxazole-5-carboxamido)-3H-imidazo[4,5-b]pyridin-3-yl)but-2-en-1-yl)-7-(3-hydroxypropoxy)-1H-benzo[d]imidazol-2-yl)-4-ethyl-2-methyloxazole-5-carboxamide
InChIKey: BSDFGBNCRMMRDC-BQYQJAHWSA-N
SMILES: O=C(C1=C(N=C(O1)C)CC)NC2=NC3=CC(C(N)=O)=CN=C3N2C/C=C/CN4C5=C(OCCCO)C=C(C(N)=O)C=C5N=C4NC(C6=C(N=C(O6)C)CC)=O
Biological Activity: STING agonist-20 (compound 95) is a potent STING agonist used in the synthesis of XMT-2056. STING agonist-20 can be used as a vaccine adjuvant in the study of cancer and other inflammatory, immune diseases[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
STING agonist-20 | 99.79% | STING agonist-20 (compound 95) is a potent STING agonist used in the synthesis of XMT-2056. STING agonist-20 can be used as a vaccine adjuvant in the study of cancer and other inflammatory, immune diseases. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
